Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Pharmacokinetics of GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, in Mice

  • 76 Accesses


This study examined the absorption and pharmacokinetic disposition of125l-GST-TatdMt, a recombinant Tat protein possessing potent anti-obesity activity, in mice after vascular and extravascular administration. GST-TatdMt was over-expressed in E. coli, purified, and radio-iodinated using the IODO-GEN method.125I-GST-TatdMt was administered to mice by i.v., i.p. and oral administration at doses of 652.7 nCi (102.3 μg). Upon i.v. injection, the average terminal elimination half-life (t1/2,λz), AUC and AUMC were 6.4 h, 318.2 nCi·h/mL and 2518 nCi·h2/ mL, respectively. The highest radioactivity was observed in lung followed by liver, spleen, heart and kidney. The t1/2,λz values obtained from i.v., i.p., and oral administration were comparable from each other (range 5.8–6.4 h). The absolute bioavailability of125I-GST-TatdMt was 42.8% and 60.5% after p.o. and i.p. administration, respectively. Given the cell-penetrating nature,125l-GST-TatdMt may be absorbed into the systemic circulation to a relatively high extent after extravascular administration.

This is a preview of subscription content, log in to check access.


  1. Brooks, H., Lebleu, B., and Vives, E., Tat peptide-mediated cellular delivery: back to basics.Adv. Drug Deliv. Rev., 57, 559–577 (2005).

  2. Ezhevsky, S. A., Nagahara, H., Vocero-Akbani, A. M., Gius, D. R., Wei, M. C., and Dowdy, S. F., Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.Proc. Natl. Acad. Sci. U.S.A., 94, 10699–10704 (1997).

  3. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J., Tat-mediated delivery of heterologous proteins into cells.Proc. Natl. Acad. Sci. U.S.A., 91, 664–668 (1994).

  4. Frankel, A. D. and Pabo, C. O., Cellular uptake of the tat protein from human immunodeficiency virus.Cell; 55, 1189–1193 (1988).

  5. Futaki, S., Membrane-permeable arginine-rich peptides and the translocation mechanisms.Adv. Drug Deliv. Rev., 57, 547–558 (2005).

  6. Hur, M. W. and Lee, D. K., Anti-obesity polypeptides. PCT/ KR02/00729 (2002).

  7. Kang, H., Delong, R., Fisher, M. H., and Juliano, R. L., Tat- conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.Pharm. Res., 22, 2099–2106 (2005).

  8. Kida, S., Maeda, M., Hojo, K., Eto, Y., Gao, J., Kurachi, S., Mizuguchi, H., Hayakawa, T., Mayumi, T., Nakagawa, S., and Kawasaki, K., Design and synthesis of a Tat-related gene transporter: A tool for carrying the adenovirus vector into cells.Bioorg. Med. Chem. Lett., 16, 743–745 (2006).

  9. Laspia, M. F., Rice, A. P., and Mathews, M. B., HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.Cell, 59, 283–292 (1989).

  10. Mann, D. A. and Frankel, A. D., Endocytosis and targeting of exogenous HIV-1 tat protein.EMBO J., 10, 1730–1739 (1991).

  11. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F., In vivo protein transduction: delivery of a biologically active protein into the mouse.Science, 285, 1569–1572 (1999).

  12. Shin, B. S., Kim, C. H., Jun, Y. S., Park, E. H., Hur, M. W., Lee, K. C., Yoon, Y. S., Lee, M. N., and Yoo, S. D., Dose- linear pharmacokinetics, tissue distribution, and excretion of a recombinant fusion protein 1251-GST-TatdMt possessing potent anti-obesity activity.Reg. Pept., 129, 25–30 (2005).

  13. Shin, B. S., Kim, C. H., Lee, M. N., Hur, M. W., Lee, K. C., Youn, Y. S., and Yoo, S. D., Pharmacokinetics of 1251-GST- TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, after intracenous, nasal, oral, and subcutaneous administration.Reg. Pept., 140, 74–80 (2007).

  14. Vives, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membranes and accumulates in the cell nucleus.J. Biol. Chem., 272, 16010–16017 (1997).

  15. Vives, E., Present and future of cell-penetrating peptide mediated delivery systems: “Is the Trojan horse too wild to go only to Tory?”J. Cont. Rel., 109, 77–85 (2005).

Download references

Author information

Correspondence to Beom Soo Shin or Jin Hyuk Seo or Man-Wook Hur or Min-Nyung Lee or Sun Dong Yoo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shin, B.S., Seo, J.H., Hur, M. et al. Pharmacokinetics of GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, in Mice. Arch Pharm Res 30, 1162–1167 (2007). https://doi.org/10.1007/BF02980253

Download citation

Key words

  • Tat
  • Pharmacokinetics
  • Bioavailability
  • Distribution
  • Obesity